Efficacy Evaluation and Mechanism Study of Nonantibiotic Nanoplatform for Clearing MRSA
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Xiangjun Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Ro…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Staphylococcal Infections, Metal Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: China Association for Science and Technology, Taishan Scholar Project of Shandong Province, Beijing Association for Science and Technology.
Abstract (Originalsprache)
The effective treatment of infections induced by biofilms has remained a substantial challenge in clinical practice. Presently, there is an imperative demand for innovative antimicrobial strategies that can not only eliminate biofilms but also incorporate controlled delivery and intelligent release mechanisms. In this research, the charge-reversible nonantibiotic nanodelivery system (MPDA/AuNCs/ICG@Lip NPs) is synthesized. Initially, AuNCs and indocyanine green (ICG) were introduced onto MPDA NPs via adsorption and mesoporous loading, followed by the modification of the phospholipids on the exterior surface. Within the biofilm microenvironment, the surface charge was reversed, thereby improving its affinity for methicillin-resistant Staphylococcus aureus (MRSA) and facilitating enhanced biofilm permeability. Owing to the ultrasmall AuNCs, they were internalized by the bacteria and, in conjunction with ICG, contributed to the elevation of local ROS concentrations under the 808 nm laser. As anticipated, the in vitro findings confirmed that MPDA/AuNCs/ICG@Lip NPs demonstrated superior biofilm-clearing capabilities and antibacterial effect. In vivo experiments corroborated that MPDA/AuNCs/ICG@Lip NPs successfully targeted the cyst site and remained localized for an extended period, resulting in excellent therapeutic efficacy. This discovery offers a novel perspective for the development of nonantibiotic nanoplatform for clearing MRSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China.
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Jinan 250000, P. R. China.
- Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital; State Key Laboratory of Kidney Diseases, Beijing 100853, P. R. China.
ORCID-Profile: Xiangjun Chen, Wenting Li, Wei Hong
Förderung
- China Association for Science and Technology
- Taishan Scholar Project of Shandong Province
- Beijing Association for Science and Technology
- Provincial-Level Leading Talent Sponsorship Program by Yantai
Zitieren
APA
Chen, X., Zhang, X., Fan, Q., Cao, M., Zhang, S., Li, W., Ma, R., Zhang, X., & Hong, W. (2025). Efficacy Evaluation and Mechanism Study of Nonantibiotic Nanoplatform for Clearing MRSA. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00097
Vancouver
Chen X, Zhang X, Fan Q, Cao M, Zhang S, Li W, et al. Efficacy Evaluation and Mechanism Study of Nonantibiotic Nanoplatform for Clearing MRSA. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00097
BibTeX
@article{Chen2025,
author = {Chen, Xiangjun and Zhang, Xinzhong and Fan, Qing and Cao, Menglin and Zhang, Sai and Li, Wenting and Ma, Rui and Zhang, Xiuping and Hong, Wei},
title = {Efficacy Evaluation and Mechanism Study of Nonantibiotic Nanoplatform for Clearing MRSA},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00097}
}
EUVIMED